Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
$1.73B |
 |
Tempus AITEM |
-$138B |
 |
SolventumSOLV |
-$1.88B |
 |
Cosmos HealthCOSM |
$113M |
 |
TeleflexTFX |
$7.4M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| LEVINE JOSHUA | May 11, 2026 | Buy | 10,000 | $4.22 | $42,000 |
FAQ - Insider Transactions
The most recent insider transaction for Edap TMS was conducted by LEVINE JOSHUA, who sold 10,000 shares on May 11, 2026 at a price of $4.22 per share.
LEVINE JOSHUA has bought the most EDAP stock in the last 2 years, with a total value of $42,000.
According to our estimates, the total value of insider transactions for Edap TMS in the last 2 years is positive, amounting to $42,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Edap TMS have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
